thiotepa has been researched along with Inappropriate ADH Syndrome in 2 studies
Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).
Inappropriate ADH Syndrome: A condition of HYPONATREMIA and renal salt loss attributed to overexpansion of BODY FLUIDS resulting from sustained release of ANTIDIURETIC HORMONES which stimulates renal resorption of water. It is characterized by normal KIDNEY function, high urine OSMOLALITY, low serum osmolality, and neurological dysfunction. Etiologies include ADH-producing neoplasms, injuries or diseases involving the HYPOTHALAMUS, the PITUITARY GLAND, and the LUNG. This syndrome can also be drug-induced.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kleta, R | 1 |
| Wagner, A | 1 |
| Jürgens, H | 1 |
| Sica, S | 1 |
| Cicconi, S | 1 |
| Sorà, F | 1 |
| Chiusolo, P | 1 |
| Piccirillo, N | 1 |
| Laurenti, L | 1 |
| La Barbera, EO | 1 |
| Giordano, G | 1 |
| Leone, G | 1 |
2 other studies available for thiotepa and Inappropriate ADH Syndrome
| Article | Year |
|---|---|
Recurrence of SIADH after a high-dose regimen of thiotepa, carboplatin, and etoposide phosphate.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemot | 1998 |
Inappropriate antidiuretic hormone secretion after high-dose thiotepa.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; C | 1999 |